Dolby Laboratories, Inc. (DLB) Stock Forecast
DLB analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.25 / 5 from 4 analysts
- Price target
- $79.00 average of analyst targets
- Upside to target
- +31.8% from the latest close
- Next earnings
- November 17, 2026 EPS estimate $0.91
- 52-week range
- $48.51 – $69.58
DLB analyst ratings
4 analystsNumber of analysts at each rating.
DLB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
DLB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.12 | $1.06 | $1.22 | $1.06 | +5.9% | 4 |
| Current fiscal year (FY2026) | $4.32 | $4.28 | $4.35 | $4.24 | +1.9% | 4 |
| Next fiscal year (FY2027) | $4.58 | $4.49 | $4.70 | $4.32 | +6.0% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
DLB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $359.3M | $353.5M | $369.4M | +3.6% | 4 |
| Current fiscal year (FY2026) | $1.43B | $1.41B | $1.45B | +5.7% | 4 |
| Next fiscal year (FY2027) | $1.47B | $1.44B | $1.51B | +2.9% | 4 |
DLB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
DLB revenue: reported and forecast
DLB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.14 | $1.14 | $1.14 | $1.12 | $1.12 | −1.2% | 1 up · 1 down |
| Current fiscal year (FY2026) | $4.32 | $4.32 | $4.33 | $4.32 | $4.32 | +0.1% | 2 up · 1 down |
| Next fiscal year (FY2027) | $4.60 | $4.59 | $4.60 | $4.58 | $4.58 | −0.5% | 1 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
DLB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; DLB beat in 12 of 12.
What analysts expect from DLB
4 analysts cover Dolby Laboratories; their consensus rating is buy (4.25 on a 1–5 scale, where 5 is a strong buy). The average price target is $79.00, 31.8% above the latest close of $59.95. Analysts expect earnings of $4.32 per share for FY2026, +1.9% from a year earlier. For FY2027 the average estimate is $4.58 per share on revenue of $1.5 billion. Dolby Laboratories beat the EPS estimate in 12 of the last 12 quarters.
Related: DLB income statement, DLB key metrics, DLB chart. See the DLB stock overview for the latest quote and news.
DLB forecast FAQ
What is Dolby Laboratories's price target?
The average analyst price target for Dolby Laboratories is $79.00, 31.8% above the latest close of $59.95.
Is Dolby Laboratories a buy, hold or sell?
Of 4 analysts covering Dolby Laboratories, 2 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Dolby Laboratories's EPS forecast?
Analysts forecast $4.32 per share for FY2026 (range $4.28 to $4.35); for FY2027 the estimate is $4.58.
What is Dolby Laboratories's revenue forecast?
The average revenue estimate for FY2026 is $1.4 billion, growth of 5.7%; for FY2027 it is $1.5 billion.
When does Dolby Laboratories report earnings?
Dolby Laboratories is expected to report results for the quarter ending September 30, 2026 on November 17, 2026 after the market closes; the EPS estimate is $0.91.
Does Dolby Laboratories usually beat earnings estimates?
Dolby Laboratories reported EPS at or above the analyst estimate in 12 of the last 12 quarters.